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INTRODUCTION:  The  incidence  of metastasis  of  hepatocellular  carcinoma  (HCC)  to  the  gallbladder  is low.
Here,  we report  a case  of HCC  with  metastasis  to the gallbladder  and  discuss  the  pattern  of spread  and
the  treatment.
PRESENTATION  OF  CASE:  A  74-year-old  man  was diagnosed  with  advanced  hepatocellular  carcinoma.
Computed  tomography  and  magnetic  resonance  imaging  demonstrated  a tumor  in the  right  lobe  of
the  liver  with  a thrombus  in the  bifurcation  of the  portal  vein.  Because  intraoperative  ultrasonogra-
phy  showed  portal  vein  tumor  thrombosis  from  the  main  tumor  reaching  the  umbilical  portion,  we
performed  only  a cholecystectomy  for the elimination  of  postoperative  cholecystitis.  Pathological  exam-
ination  showed  gallbladder  vein  tumor  thrombosis  from  poorly  differentiated  hepatocellular  carcinoma.
DISCUSSION:  A  preoperative  diagnosis  of metastatic  HCC  to the  gallbladder  is difﬁcult  because  there  are  no
speciﬁc  ﬁndings  in  the  imaging  tests.  Cancer  cells  in the  liver  were  thought  to  migrate  to  the  gallbladder
via  the  connection  between  the  portal  system  and  the  cholecystic  veins,  and  grow  in the  lumen of  the
veins  in our  case.  The  survival  rate,  in  all reported  cases  including  the  present  case,  was increased  in
patients  who  underwent  radical  resection,  compared  to  patients  who  underwent  palliative  surgery.
CONCLUSION: The  resection  of  metastatic  HCC  to the  gallbladder  might  appear  to  prolong  survival.
gical .© 2012 Sur
. Introduction
Hepatocellular carcinoma (HCC) commonly shows intrahepatic
pread, compared to extrahepatic metastasis, even in advanced-
tage tumors. The majority of extrahepatic metastasis lesions are
ound in the lungs, lymph nodes, and bones.1–3 The incidence of
etastasis of HCC to the gallbladder is low. There have been some
linical reports of cases with metastatic tumors of the gallbladder
etected while the patient is alive. Here, we report a case of HCC
ith metastasis to the gallbladder and discuss the pattern of spread
nd the treatment.
.  Presentation of case
A 74-year-old man  was referred to our hospital because his
aboratory proﬁle showed elevated levels of transaminase in
pril 2011. He had no symptoms. His laboratory proﬁle showed
levated levels of aspartate aminotransferase (51 U/L), alanine
ransferase (47 U/L). He had a total bilirubin level of 0.7 mg/dL. The
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indocyanine green retention rate at 15 min  was 12.9%. The level of
protein induced by vitamin K absence or antagonist II (PIVKA-II) and
serum -fetoprotein were elevated: 33,553 mAU/mL  for PIVKA-
II and 48,860 ng/mL for serum -fetoprotein. Hepatitis B surface
antigen and hepatitis C virus antibody were negative. Computed
tomography demonstrated a tumor measuring 88 mm × 70 mm in
diameter in S1/5/6/7/8 of the liver (Fig. 1a). This tumor showed con-
trast enhancement in the hepatic arterial phase and then became
less dense than the liver parenchyma in the portal phase. Mul-
tiple satellite nodules were also seen around the main tumor.
Tumor thrombus was  seen in the bifurcation between the right
and the left branches of the portal vein (Fig. 1b). Magnetic res-
onance imaging using gadoxetate acid demonstrated that these
tumors showed a pattern of early enhancement and washout. An
angiographic examination showed that the satellite nodules were
fed by the proper hepatic artery. The right branch of the portal
vein was  not demonstrated in the portal phase. The gallbladder
was intact in these imaging tests (Fig. 1c). Therefore, the diag-
nosis was HCC (T3N0M0 Stage IIIA according to the International
Union Against Cancer classiﬁcation) in the right lobe, with tumor
Open access under CC BY-NC-ND licensethrombus reaching the bifurcation of the portal vein. Following
transarterial chemoembolization, we  intended to perform right
and caudate lobectomies of the liver and a cholecystectomy in
August 2011. During surgery, no peritoneal dissemination, ascites,
 BY-NC-ND license.
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sig. 1. (a) Computed tomography scan showing a 88-mm ×70-mm tumor in the r
arrow). (c) The gallbladder appears normal.
r lymph node metastasis was observed, but intraoperative ultra-
onography showed that the portal vein tumor thrombosis from
he main tumor reached the umbilical portion of the left lobe of
he liver (Fig. 2). We only conducted a cholecystectomy for the
limination of postoperative cholecystitis, because the patient’s
iver reserve was not enough for an extended right hepatectomy.
acroscopically, no tumor was found on the surface of the gall-
ladder (Fig. 3a). Pathological examination showed that the tumor
ells consisted of alveolar or trabecular cells with eosinophilic
ytoplasm and diffuse invasion of the veins in the mucosal and
ubmucosal layers of the gallbladder as gallbladder tumor throm-
osis (Fig. 3b and c). The ﬁnal diagnosis was HCC with gallbladder
etastasis.
The patient made an uneventful recovery. Sorafenib wasntroduced for the treatment of HCC, but his condition gradu-
lly deteriorated and he died in October 2011, 2 months after
urgery.
Fig. 2. Intraoperative ultrasonography showing that a portal vein tumor thrombus fbe of the liver. (b) A tumor thrombus is seen in the bifurcation of the portal vein
3. Discussion
A  metastatic tumor of the gallbladder is rare. An autopsy series
represented the incidence of metastatic tumor of the gallbladder in
1000 cases to be 5.8%.4 The most common primary carcinoma lead-
ing to a metastatic tumor of the gallbladder is malignant melanoma.
Das Gupta and Brasﬁeld found a 15% incidence of gallbladder
metastasis in patients dying from malignant melanoma.5 Extrahe-
patic metastasis of HCC is rather common. Recent clinical follow-up
studies found the incidence of extrahepatic metastasis of HCC to
be 13.5–36.7%.1–3 Uchino3 reported that the distribution of the
metastatic sites of HCC was lungs in 135 patients (39.5%), lymph
nodes in 117 patients (34.2%), bones in 87 patients (25.4%), adrenal
glands in 30 patients (8.8%), brain in 4 patients (1.2%), spleen in
2 patients (0.6%), and breast in 1 patient (0.3%), for a total of 376
extrahepatic occurrences in 342 patients. The incidence of metasta-
sis of HCC to the gallbladder is 2.8–5.8% of extrahepatic metastasis
rom the main tumor reached the umbilical portion of the left lobe of the liver.
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aig. 3. (a) Macroscopically, no tumorous lesion is seen in the mucosa or wall of th
n the gallbladder veins (hematoxylin and eosin, 10×). (c) Pathological examination
ytoplasm and diffuse invasion of the veins in the mucosal and submucosal layers o
n an autopsy series.6,7 However, there have been a few clinical
eports of cases with metastatic tumor of the gallbladder detected
hile the patient was alive. There have been 16 reported cases of
etastatic HCC to the gallbladder. The resected cases of metastatic
CC to the gallbladder are shown in Tables 1 and 2.8–15
A preoperative diagnosis of metastatic HCC to the gallblad-
er is difﬁcult. Two patients required cholecystectomy due to
holecystitis.9,10 Although imaging showed wall thickening or
umorous lesions of the gallbladder in some cases, there are no
peciﬁc ﬁndings in the imaging tests of metastatic HCC to the
able 1
linical characteristics of metastatic hepatocellular carcinoma to the gallbladder.
Case First author Year Age/sex Background Preoperative
image of gall
bladder
Evid
chol
1 Maruo8 1994 73/M Non B non C np − 
2  Nishida9 1997 48/M HBV GB dilation + 
3  Lane10 2002 78/M NA GB dilation + 
4  Terashima11 2007 49/M HBV Well
demarcated,
enhanced
polypoid mass
−  
5  Ando12 2009 75/M HCV Well
demarcated,
enhanced
tumor
−  
6  Murakami13 2010 53/M HBV Alc GS − 
7 61/M  HCV np − 
8  79/M Alc Wall thickness − 
9  47/M HBV GB dilation − 
10  47/M HBV np − 
11  32/M HBV Alc np − 
12  74/M HCV Wall thickness − 
13  66/M Alc np − 
14  Monden14 2011 66/M HCV Polypoid mass − 
15  Kanzaki15 2011 48/F Non B non C Round-shaped
tumor
−  
16  Our case 2012 74/M HCV np − 
BV, hepatitis B virus; HCV, hepatitis C virus; Alc, alcoholic hepatitis; np, nothing particu
vailable.bladder. (b) Histopathological staining showing a representative tumor thrombus
ing that the tumor cells consisted of alveolar or trabecular cells with eosinophilic
gallbladder as a tumor thrombosis (hematoxylin and eosin, 100×).
gallbladder.  In our case, the gallbladder metastasis was identiﬁed
only by histopathological examination after the cholecystectomy
because the surface of the gallbladder macroscopically appeared
almost normal.
The  location of the primary tumor was  at or near the center
of the gallbladder bed. Thirteen of the 16 reported cases had a
primary tumor in S4 or 5 and 11 of 14 patients had portal vein
tumor thrombosis. Five cases, including our case, showed only gall-
bladder tumor thrombosis without an apparent tumor mass in the
mucosa or wall. Nakashima et al.7 proposed four possible routes
ence  of
ecystitis
HCC  Synchronous (S)
or  metachronous
(M)
PVTT
Location Size (cm) Number
S4 48 St S −
S4/5 NA Mt  S +
Right lobe NA Mt  S NA
S5/6/7/8 10.7 Mt  M +
NA NA Mt  S NA
S7/8 14 Mt  S +
S5/8 9.5 Mt  S +
S2/3/4 13 Mt  S +
S4 6.5 Mt  S +
S2/3/4 13 Mt  S +
S5/6/7/8 15 Mt  S +
S5/6 5 St S +
S5/8 3.5 Mt  S +
S5/8 NA St M −
S5 1.3 St S −
S1/5/6/7/8 88 Mt  S +
lar; GB, gallbladder; GS, gallstones; Mt,  multiple tumors; St, single tumor; NA, not
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Table 2
Treatment, histopathological characteristics, and outcome.
Case Preoperative treatment Operation Residual
tumor
Postoperative
therapy
Morphologic type Histological
type
Prognosis
1 None Left + chole 0 Omentectomy
TAE
Elevated Mod  32 mo  alive
2  None Chole 2 NA Diffuse invasion to the
muscularis  propria and
submucosal  layer
Mod  NA
3  None Chole 2 NA GBTT Well Died of pneumonia
4 IFN
TAI
Chole 0 Hepatectomy
TAI
Polypoid mass Mod  13 mo  alive
5  TACE RFA Chole NA NA Pedunculated tumor NA NA
6  None Right + chole 0 FAIT GBTT Poor 63 mo  alive
7  None E-Right + chole 0 FAIT GBTT Poor 4 mo alive
8  None E-Left + chole 2 FAIT GBTT Mod  6 mo dead
9 None Left  + chole 0 FAIT NA  (mp) Poor 54  mo  dead
10  TACE E-Left + chole 2 FAIT NA (mp) Poor 9 mo dead
11 None  E-right + chole 2 FAIT NA (mp) Poor 3 mo dead
12  TACE Right + chole 0 None NA (sm) Poor 5 mo dead
13 TACE Ant  + chole 2 None Protruding (m-mp) Poor 6 mo dead
14  TAE RFA HIMAC Chole 0 None Elevated + diffuse Mod  10 mo alive
15 En  bloc resection of gallbladder
and  the liver surrounding the
gallbladder
Chole 0 None Mass located below serosa Mod  24 mo  alive
16  TACE Chole 2 Sorafenib GBTT Poor 2 mo dead
IFN, interferon; TAI, transcatheter hepatic arterial infusion; RFA, radiofrequency ablation; TACE, transarterial chemoembolization; TAE, transcatheter hepatic arterial emboliza-
tion  HIMAC, heavy-ion medical accelerator complex; Left, left hepatectomy; chole, cholecystectomy; Right, right hepatectomy; E-, extended; Ant, anterior segmentectomy;
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onth.
y which HCC can involve the gallbladder: (i) the hematogenous
oute via the portal venous system, usually with portal vein tumor
hrombosis, (ii) the lymphogenous route, (iii) the route of direct
nvasion of HCC from the liver, and (iv) metastasis to the gallblad-
er with peritoneal dissemination of HCC. They reported that tumor
rowth was found in the portal trunk or in the major portal branch
t the hilum in 150 (64.7%) of 232 cases and that the majority of
he gallbladder metastasis of HCC occurred by the hematogenous
oute via the portal venous system. Some cases with only tumor
hrombosis in the cholecystic veins without any invasion to the
allbladder wall were also seen in their series. Anatomically, all
holecystic veins enter the right anterior branch of the portal vein
ystem through the liver bed of the gallbladder through Calot’s
riangle.16 In our case, cancer cells in the liver were thought to
igrate to the gallbladder via the connection between the portal
ystem and the cholecystic veins, and grow in the lumen of the
eins.
In general, the indications for resection of the extrahepatic
etastasis of HCC are limited because of the poor survival rate.17
chino et al.3 reported that the cumulative survival rates after the
iagnosis of extrahepatic metastasis were 39.3% at 1 year, 15.3% at
 years, 7.4% at 3 years, and 4% at 5 years and that the median
urvival was 8.1 months (range, from 1 day to 108.7 months).
hey concluded that the major cause of death in patients with HCC
ho have extrahepatic metastasis is progression of the intrahepatic
CC lesion and that the extrahepatic metastasis is not the direct
ause of death in the majority of affected patients. A pulmonary
etastasectomy is associated with good outcomes in selected
atients.18 There are few reports of the resection of metastatic HCC
n sites other than lung, but a metastasectomy appears to prolong
urvival.19
The survival rate, in all reported cases including the present
ase, was increased in patients who underwent radical resection,
ompared to patients who  underwent palliative surgery, which
uggests that radical resection might be the more useful method
or curability.15 Although strong evidence is lacking to support
n aggressive approach to resection, it seems reasonable to per-
orm radical resections for patients with potentially curable disease; GBTT, gallbladder vein tumor thrombus; Mod, moderate; NA, not available: mo,
and  to produce a satisfactory local response. More experience and
long-term follow-up is necessary to justify the risks of surgical
resection.
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